Donor-derived infections in solid organ transplant recipients

American Journal of Transplantation

Volumn 9, Issue SUPPL. 4, 2009, Pages

  Grossi, P A ^a,b   Fishman, J A ^c  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b National Transplant Centre   (Italy)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Donor safety; Donor testing; High risk donor; Infection; Transplantation; Window period

Indexed keywords

ANTIBIOTIC AGENT; ANTIVIRUS AGENT; CYTOMEGALOVIRUS ANTIBODY; VIRUS ANTIBODY;

ALLOGRAFT; ANAMNESIS; ANTIBIOTIC PROPHYLAXIS; ANTIMICROBIAL THERAPY; BACTERIAL INFECTION; BLOOD CULTURE; BLOOD SAMPLING; CHIKUNGUNYA ALPHAVIRUS; COCCIDIOIDES; DIAGNOSTIC TEST; DISEASE TRANSMISSION; DONOR SELECTION; EPSTEIN BARR VIRUS; EXPOSURE; FALSE POSITIVE RESULT; GRAFT INFECTION; HEMODILUTION; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HERPES SIMPLEX VIRUS; HIGH RISK POPULATION; HISTOPLASMA; HISTOPLASMA CAPSULATUM; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T CELL LEUKEMIA VIRUS; INFECTION RISK; INFORMED CONSENT; LEISHMANIA; MORBIDITY; MORTALITY; MYCOBACTERIUM TUBERCULOSIS; MYCOSIS; NEWBORN SCREENING; NUCLEIC ACID AMPLIFICATION; NUCLEIC ACID ANALYSIS; ORGAN DONOR; ORGAN TRANSPLANTATION; PHYSICAL EXAMINATION; PLASMODIUM; PRACTICE GUIDELINE; PRIORITY JOURNAL; RABIES VIRUS; REVIEW; SCREENING; SEROLOGY; STRONGYLOIDES; TOXOPLASMA; TREPONEMA PALLIDUM; TRYPANOSOMA CRUZI; URINE CULTURE; VARICELLA ZOSTER VIRUS; VIREMIA; VIRUS TRANSMISSION; WEST NILE FLAVIVIRUS;

HUMANS; INFECTION; RISK FACTORS; TISSUE DONORS; TRANSPLANTATION;

EID: 72949090189     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02889.x     Document Type: Review

References (71)

1. Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med 2007 357 : 2601 2614.
2. Fischer SA, Graham MB, Kuehnert MJ et al. LCMV in Transplant Recipients Investigation Team. Transmission of lymphocytic choriomeningitis virus by organ transplantation. N Engl J Med 2006 354 : 2235 2249.
3. Palacios G, Druce J, Du L et al. A new arenavirus in a cluster of fatal transplant-associated diseases. N Engl JMed 2008 358 : 991 998.
4. Lymphocytic Choriomeningitis Virus Transmitted Through Solid Organ Transplantation - Massachusetts, 2008. MMWR 2008 29 : 799 801.
5. Kiberd BA, Forward K. Screening for West Nile virus in organ transplantation: A medical decision analysis. Am J Transplant 2004 4 : 1296 1301.
6. Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med 1998 338 : 1741 1751.
7. Delmonico FL, Snydman DR. Organ donor screening for infectious diseases: Review of practice and implications for transplantation. Transplantation 1998 65 : 603 610.
8. Avery RK. Recipient screening prior to solid-organ transplantation. Clin Infect Dis 2002 35 : 1513 1519.
9. Infectious Diseases Community of Practice of the American Society for Transplantation. Screening of donor and recipient prior to solid organ transplantation. Am J Transplant 2004 4 (Suppl 10 10 20.
10. Organ Procurement and Transplantation Network. Minimum procurement standards for an organ procurement organization. Richmond, VA : United Network for Organ Sharing, 2005. http://www.optn.org/policiesandbylaws. Last accessed December 14, 2008.
11. Fishman JA. Infection in Solid-Organ Transplant Recipients. N Engl J Med 2007 357 : 2601 2614.
12. COMMISSION DIRECTIVE 2006/17/EC of 8 February 2006. Implementing Directive 2004/23/EC of the European Parliament and of the Council as regards certain technical requirements for the donation, procurement and testing of human tissues and cells. Off J Eur. Un. 2006 L38 : 40 52.
13. Iwamoto M, Jernigan DB, Guasch A et al., the West Nile Virus in Transplant Recipients Investigation Team. Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med 2003 348 : 2196 2203.
14. Teperman LW, Diflo T, Fahmy A et al. West Nile virus infections in organ transplant recipients-New York and Pennsylvania, August-September, 2005. MMWR Morb Mortal Wkly Rep 2005 54 : 1021 1023.
15. Nanni Costa A, Grossi P, Porta E, Venettoni S, Fehily D. Measures taken to reduce the risk of West Nile virus transmission by transplantation in Italy. Eurosurveillance 2008 13 : 1 2.
16. Martín-Dávila P, Fortún J, López-Vélez R et al. Transmission of Tropical and Geographically Restricted Infections during Solid-Organ Transplantation. Clinical Microbiology Reviews 2008 21 : 60 96.
17. Casper C, Krantz EM, Corey L et al. Valganciclovir for suppression of human herpesvirus-8 replication: A randomized, double-blind, placebo-controlled, crossover trial. J Infect Dis 2008 198 : 23 30.
18. Angelis M, Cooper JT, Freeman RB. Impact of donor infections on outcome of orthotopic liver transplantation. Liver Transplantation 2003 9 : 451 462.
19. Delmonico FL. Cadaver donor screening for infectious agents in solid organ transplantation. Clin Infect Dis 2000 31 : 781 786.
20. Freeman RB, Giatras I, Falagas ME et al. Outcome of transplantation of organs procured from bacteremic donors. Transplantation 1999 68 : 1107 1111.
21. Nanni Costa A, Grossi PA, Gianelli Castiglione A, Grigioni WF. Quality and safety in the Italian donor evaluation process. Transplantation 2008 85 : S52 S56.
22. Carlos Lumbreras, Francisca Sanz, Almudena Gonzalez et al. Clinical significance of donor-unrecognized bacteremia in the outcome of solid-organ transplant recipients. Clin Infect Dis 2001 33 : 722 726.
23. Singh N. Impact of donor bacteremia on outcome in organ transplant recipients. Liver Transplant 2002 8 : 975 976.
24. Paredes D, Gambra MP, Cervera C et al. Characterization of the organ donor with bacteremia. Transplant Proc 2007 39 : 2083 2085.
25. Satoi S, Bramhall SR, Solomon M et al. The use of liver grafts from donors with bacterial meningitis. Transplantation 2001 72 : 1108 1113.
26. Sözen H, Fidan K, Mahli A et al. Successful solid organ transplantation from septicemic cadaveric donors: Case report. Transplant Proc 2008 40 : 299 301.
27. Len O, Gavaldà J, Blanes M et al. Spanish Research Network for the Study of Infection in Transplantation. Donor infection and transmission to the recipient of a solid allograft. Am J Transplant 2008 8 : 2420 2425.
28. D'albuquerque L, Gonzalez A, Filho H et al. Liver transplantation from deceased donors serologically positive for Chagas disease. Am J Transplant 2007 7 : 680 684.
29. Seehofer D, Berg T. Prevention of hepatitis B recurrence after liver transplantation. Transplantation 2005 80 (1 Suppl S120 S124.
30. Trautwein C. Mechanisms of hepatitis B virus graft reinfection and graft damage after liver transplantation. J Hepatol 2004 41 : 362 369.
31. Madayag RM, Johnson LB, Bartlett ST et al. Use of renal allografts from donors positive for hepatitis B core antibody confers minimal risk for subsequent development of clinical hepatitis B virus disease. Transplantation 1997 64 : 1781 1786.
32. de Villa VH, Chen YS, Chen CL. Hepatitis B core antibody-positive grafts: recipient's risk. Transplantation 2003 75 (3 Suppl S49 S53.
33. De Feo TM, Grossi P, Poli F et al. Kidney transplantation from anti-HBc+ donors: results from a retrospective Italian study. Transplantation 2006 81 : 76 80.
34. Marzano A, Angelucci E, Andreone P et al Italian Association for the Study of the Liver. Prophylaxis and treatment of hepatitis B in immunocompromised patients. Dig Liver Dis 2007 39 : 397 408.
35. Chazouilleres O, Wright TL. Hepatitis C and liver transplantation. J Gastroenterol Hepatol 1995 10 : 471 480.
36. Fishman JA, Rubin RH, Koziel MJ, Periera BJ. Hepatitis C virus and organ transplantation. Transplantation 1996 62 : 147 154.
37. Everhart JE, Wei Y, Eng H et al. Recurrent and new hepatitis C virus infection after liver transplantation. [erratum appears in Hepatology 1999; 30: 1110]. Hepatology 1999 29 : 1220 1226.
38. Feray C, Shouval D, Samuel D. Will transplantation of a hepatitis C-infected graft improve the outcome of liver transplantation in HCV patients? Gastroenterology 1999 117 : 263 265.
39. Vargas HE, Laskus T, Wang LF et al. Outcome of liver transplantation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts. Gastroenterology 1999 117 : 149 153.
40. Lyra AC, Yusim K, Everhart JE et al. Liver transplantation with hepatitis C virus-infected graft: Interaction between donor and recipient viral strains. Hepatology 2003 38 : 25 33.
41. Arenas JI, Vargas HE, Rakela J. The use of hepatitis C-infected grafts in liver transplantation. Liver Transpl 2003 9 : S48 S51.
42. Eastlund T, Tomford W. The effect of long term frozen storage and freeze thaws on tissue donor serum infectious disease test performance. Tissue Cell Rep 1995 2 : 18 19.
43. Busch MP, Wilbur JC, Johnson P, Tobler L, Evans CS. Impact of specimen handling and storage on detection of hepatitis C virus RNA. Transfusion 1992 33 : 420 425.
44. José M, Gajardo R, Jorquera JI. Stability of HCV, HIV-1 and HBV nucleic acids in plasma samples under long-term storage. Biologicals 2005 33 : 9 16.
45. Eastlund T. Hemodilution due to blood loss and transfusion and reliability of cadaver tissue donor infectious disease testing. Cell Tissue Bank 2000 1 : 121 127.
46. Guidance for Industry. Eligibility determination for donors of human cells, tissues, and cellular and tissue-based products (HCT/Ps). http://www.fda.gov/cber/gdlns/tissdonor.htm (accessed December 14, 2008).
47. Yao F, Seed C, Farrugia A et al. The risk of HIV, HBV, HCV and HTLV infection among musculoskeletal tissue donors in Australia. Am J Transplant 2007 7 : 2723 2726.
48. Busch MP, Lee LL, Satten GA et al. Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors. Transfusion 1995 35 : 91 97.
49. Busch MP, Glynn SA, Stramer SL et al. A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion 2005 45 : 254 264.
50. Fiebig EW, Wright DJ, Rawal BD et al. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 2003 17 : 1871 1879.
51. Kolk DP, Dockter J, Linnen J et al. Significant closure of the human immunodeficiency virus type 1 and hepatitis C virus preseroconversion detection windows with a transcription-mediated-amplification-driven assay. J Clin Microbiol 2002 40 : 1761 1766.
52. Zou S, Dodd RY, Stramer SL, Strong DM for the Tissue Safety Study Group. Probability of Viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States. N Engl J Med 2004 351 : 751 759.
53. Yao F, Seed C, Farrugia A et al. The risk of HIV, HBV, HCV and HTLV infection among musculoskeletal tissue donors in Australia. Am J Transplant 2007 7 : 2723 2726.
54. Biswas R, Tabor E, Hsia CC et al. Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection. Transfusion 2003 43 : 788 798.
55. Kleinman SH, Busch MP. Assessing the impact of HBV NAT on window period reduction and residual risk. J Clin Virol 2006 36 (Suppl 1 S23 S29.
56. Busch MP. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors? Transfus Clin Biol 2004 11 : 26 32.
57. Kleinman SH, Kuhns MC, Todd DS et al. Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screening. Transfusion 2003 43 : 696 704.
58. Pillonel J, Saura C, Courouce AM. Prevalence of HIV, HTLV, and hepatitis B and C viruses in blood donors in France, 1992-1996. Transfus Clin Biol 1998 5 : 305 312.
59. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 1996 334 : 1685 1690.
60. Quarto M, Germinario C, Fontana A, Barbuti S. HIV transmission through kidney transplantation from a living donor. N Engl J Med 1989 320 : 1754.
61. Samuel D, Castaing D, Adam R et al. Fatal acute HIV infection with aplastic anaemia, transmitted by liver graft. Lancet 1988 1 : 1221 1222.
62. Simonds RJ, Holmberg SD, Hurwitz RL et al. Transmission of human immunodeficiency virus type 1 from a seronegative organ and tissue donor. N Engl J Med 1992 326 : 726 732.
63. Centers for Disease Control. Human immunodeficiency virus infection transmitted from an organ donor screened for HIV antibody - North Carolina. MMWR Morb Mortal Wkly Rep 1987 36 : 306 308.
64. Prompt CA, Reiss MM, Grillo FM et al. Transmission of AIDS virus at renal transplantation. Lancet 1985 2 : 672.
65. Schwarz A, Hoffmann F, L'Age-Stehr J, Tegzess AM, Offermann G. Human immunodeficiency virus transmission by organ donation. Transplantation 1987 44 : 21 24.
66. L'Age-Stehr J, Schwarz A, Offermann G et al. HTLV-III infection in kidney transplant recipients. Lancet 1985 2 : 1361 1362.
67. Kumar P, Pearson JE, Martin DH et al. Transmission of human immunodeficiency virus by transplantation of a renal allograft, with development of the acquired immunodeficiency syndrome. Ann Intern Med 1987 106 : 244 245.
68. Villa E, Nanni Costa A. HIV-positive organs used for transplant in Italy due to human error. Euro Surveill 2007 12 : E070322.5.
69. Ahn J, Cohen SM. Transmission of human immunodeficiency virus and hepatitis C virus through liver transplantation. Liver Transplant 2008 14 : 1603 1608.
70. Rogers MF, Simonds RJ, Lawton KE et al. National Center for Infectious Diseases. Guidelines for preventing transmission of human immunodeficiency virus through transplantation of human tissue and organs. MMWR 1994 43 : 1 17. Available at : http://www.cdc.gov/MMWR/preview/mmwrhtml/00031670.htm
71. United Network for Organ Sharing. Summary of actions taken at the OPTN/UNOS Executive Committee Meeting - December 18, 2007. Available at : http://www.unos.org. Accessed December 2008.